Metachronous hepatocellular carcinoma after partial response of advanced intrahepatic cholangiocarcinoma treated with radiotherapy combined with apatinib and camrelizumab: a case report.

AiTan (rivoceranib) - Elevar Therapeutics

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42211508

Dachao Chen; Nana Zhang; Shufeng Wu; Xiangbin Tan; Xianying Chen; Yuehua Geng; YuJuan Dai

May 30, 2026